Mostrar el registro sencillo del ítem
1-(Benzenesulfonyl)-1,5-dihydro-4,1-benzoxazepine as a new scaffold for the design of antitumor compounds
dc.contributor.author | Cruz López, Olga | |
dc.contributor.author | Ramirez, Alberto | |
dc.contributor.author | Navarro Marchal, Saul Abenhamar | |
dc.contributor.author | García, María A | |
dc.contributor.author | Marchal Corrales, Juan Antonio | |
dc.contributor.author | Campos Rosa, Joaquín María | |
dc.contributor.author | Conejo García, Ana | |
dc.date.accessioned | 2024-02-01T12:20:54Z | |
dc.date.available | 2024-02-01T12:20:54Z | |
dc.date.issued | 2017 | |
dc.identifier.uri | https://hdl.handle.net/10481/87935 | |
dc.description.abstract | Aim: Bozepinib is a potent and selective anticancer compound which chemical structure is made up of a benzofused seven-membered ring and a purine moiety. We previously demonstrated that the purine fragment does not exert antiproliferative effect per se. Methodology: A series of 1-(benzenesulfonyl)-4,1-benzoxazepine derivatives were synthesized in order to study the influence of the benzofused seven-membered ring in the biological activity of bozepinib by means of antiproliferative, cell cycle and apoptosis studies. Results & conclusion: Our results show that the methyleneoxy enamine sulfonyl function is essential in the antitumor activity of the structures and thus, it is a scaffold suitable for further modification with a view to obtain more potent antitumor compounds. | es_ES |
dc.language.iso | eng | es_ES |
dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 Internacional | * |
dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ | * |
dc.title | 1-(Benzenesulfonyl)-1,5-dihydro-4,1-benzoxazepine as a new scaffold for the design of antitumor compounds | es_ES |
dc.type | journal article | es_ES |
dc.rights.accessRights | open access | es_ES |
dc.identifier.doi | 10.4155/fmc-2017-0006 |